Evidence map›Paper›PMID 29439653›Full record

ArticleBMC gastroenterology2018

Unexplained chronic liver disease in Ethiopia: a cross-sectional study.

Stian Magnus Staurung Orlien, Nejib Yusuf Ismael, Tekabe Abdosh Ahmed, Nega Berhe, Trine Lauritzen, Borghild Roald, Robert David Goldin, Kathrine Stene-Johansen, Anne Margarita Dyrhol-Riise, Svein Gunnar Gundersen and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Prevalence and Spectrum of Chronic Liver Disease Among Patients Seeking Health Care in Ghana.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Contribution of Aflatoxin BInternational journal of general medicine · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Stian Magnus Staurung OrlienRegional Centre for Imported and Tropical Diseases, Oslo University Hospital Ullevål, Oslo, Norway.
Nejib Yusuf IsmaelDepartment of Internal Medicine, Hiwot Fana Specialized University Hospital, Harar, Ethiopia.
Tekabe Abdosh AhmedHaramaya University College of Health and Medical Sciences, Harar, Ethiopia.
Nega BerheRegional Centre for Imported and Tropical Diseases, Oslo University Hospital Ullevål, Oslo, Norway.
Trine LauritzenDepartment of Medical Biochemistry, Vestre Viken Hospital Trust, Drammen, Norway.
Borghild RoaldDepartment of Pathology, Oslo University Hospital Ullevål, Oslo, Norway.
Robert David GoldinCentre for Pathology, Imperial College London, London, UK.
Kathrine Stene-JohansenDepartment of Molecular Biology, Norwegian Institute of Public Health, Oslo, Norway.
Anne Margarita Dyrhol-RiiseInstitute of Clinical Medicine, Faculty of Medicine, Oslo University, Oslo, Norway.
Svein Gunnar GundersenResearch Unit, Sørlandet Hospital HF, Kristiansand, Norway.
Marsha Yvonne MorganUCL Institute for Liver & Digestive Health, Division of Medicine, University College London, Royal Free Campus, London, UK.
Asgeir JohannessenRegional Centre for Imported and Tropical Diseases, Oslo University Hospital Ullevål, Oslo, Norway. johannessen.asgeir@gmail.com.ORCID http://orcid.org/0000-0001-5966-7166
Oslo University Hospital · NOHaramaya University · ETImperial College London · GBNorwegian Institute of Public Health · NOThe Royal Free Hospital · GBUniversity of Agder · NOVestre Viken Hospital Trust · NO

Funding

Helse Sør-Øst RHF (NO) 2011068Norges Forskningsråd 220622/H10
6 · The paper itself

Abstract

backgroundHepatitis B virus (HBV) infection is assumed to be the major cause of chronic liver disease (CLD) in sub-Saharan Africa. The contribution of other aetiological causes of CLD is less well documented and hence opportunities to modulate other potential risk factors are being lost. The aims of this study were to explore the aetiological spectrum of CLD in eastern Ethiopia and to identify plausible underlying risk factors for its development.

methodsA cross-sectional study was undertaken between April 2015 and April 2016 in two public hospitals in Harar, eastern Ethiopia. The study population comprised of consenting adults with clinical and radiological evidence of chronic liver disease. The baseline evaluation included: (i) a semi-structured interview designed to obtain information about the ingestion of alcohol, herbal medicines and local recreational drugs such as khat (Catha edulis); (ii) clinical examination; (iii) extensive laboratory testing; and, (iv) abdominal ultrasonography.

resultsOne-hundred-and-fifty patients with CLD (men 72.0%; median age 30 [interquartile range 25-40] years) were included. CLD was attributed to chronic HBV infection in 55 (36.7%) individuals; other aetiological agents were identified in a further 12 (8.0%). No aetiological factors were identified in the remaining 83 (55.3%) patients. The overall prevalence of daily khat use was 78.0%, while alcohol abuse, defined as > 20 g/day in women and > 30 g/day in men, was rare (2.0%). Histological features of toxic liver injury were observed in a subset of patients with unexplained liver injury who underwent liver biopsy.

conclusionThe aetiology of CLD in eastern Ethiopia is largely unexplained. The widespread use of khat in the region, together with histopathological findings indicating toxic liver injury, suggests an association which warrants further investigation.

Indexed as

Acute Lung InjuryAdultAlcoholismBiopsyCathaChronic DiseaseCross-Sectional StudiesEthiopiaFemaleHumansLiverLiver DiseasesMalePrevalenceRisk FactorsSubstance-Related DisordersCatha edulisEpidemiologyHepatotoxicitySub-Saharan AfricaViral hepatitis

Identifiers

PMID29439653
PMCPMC5812015
OpenAlexW2788520726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.